Zenas Biopharma Inc (ZBIO)

R&D Expense Growth

4.09%

Quarterly · Period ending:

ZBIO logo

ZBIO R&D Expense Growth

Latest reported4.09%
ZBIO Quarterly R&D Growth (QoQ) (0.00% → 4.09%)
High-resolution chart · PNG

ZBIO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zenas Biopharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
4.0934%
-72.8232%
546.4508%
-20.0456%
23.2336%
-28.9725%
46.606%
-0.8194%
49.2912%
10.907%
118.3276%
-37.298%
-2.8149%
-2.6514%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.